Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development.

Abstract excerpt

Pancreatic cancer has become the third leading cause of cancer-related death, with little improvement in outcomes despite decades of research. Surgery remains the only chance of cure, yet only 20% of patients will be alive at 5 years after pancreatic resection. Few chemotherapeutics provide any improvement in outcome, and even then, for approved therapies, the survival benefits are marginal. Genomic sequencing...

Topics

Join the communities discussing this publication.

• Genomics
• High-Throughput Nucleotide Sequencing
• Molecular Targeted Therapy
• Mutation
• Pancreatic Neoplasms